Updated:
Re:Ventures
Re:Ventures operates out of Daejeon, South Korea, as a privately held accelerator that has formed multiple funds, including a mother fund and private vehicles...
Re:Ventures
Re:Ventures operates out of Daejeon, South Korea, as a privately held accelerator that has formed multiple funds, including a mother fund and private vehicles exceeding KRW 100 billion in aggregate. The firm describes its mission as enabling startups to realize a vision while delivering positive experiences to limited partners. Deployment spans venture capital across seed, start-up, and growth stages. The portfolio concentrates on deep-tech and consumer services with confirmed positions in Rebellions, a fabless AI-chip company; Connetive, which builds AI-powered orthopedic surgical robots and imaging software; MyNormal Company, a zero-sugar health-food brand; Paiptree, an AI-driven poultry-farm management platform; Charaan, a fashion recommerce marketplace operated by MINE’S; and Doctor Now, a physician-consult and digital-health platform. Geographic reach centers on South Korea, though portfolio companies are pushing into the Middle East, Japan, and Southeast Asia — Rebellions has partnered with Saudi Aramco’s CVC Wa’ed Ventures and field-tests its NPU with IBM in the US. Re:Ventures functions as a structured accelerator, not an institutional venture firm — its model blends direct equity investments with partnerships under Korea’s TIPS (Tech Incubator Program for Startup) designation. The team size is undisclosed, and the firm has no known additional offices. Portfolio companies have achieved notable fundraising milestones: Rebellions closed a KRW 165 billion Series B; Charaan operator MINE’S raised KRW 10 billion in a Series A; Connetive completed a KRW 4 billion pre-A round that Re:Ventures co-invested in via an individual investment association. Re:Ventures' structural distinction lies in its position as a TIPS operator — one of the South Korean government's official technology-acceleration platforms, which allows it to combine public R&D grants with privately raised capital and to deploy into startups before their institutional Series-A phase. This dual-source funding model, uncommon among family offices and traditional VCs, shapes a pipeline that bridges government-backed innovation programs to commercial scale-up rounds.
General information
Firm type
Private Equity
Year founded
2020
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Daejeon
Corporate office
Daejeon, South Korea
Sector focus
Frequently asked questions
Is Re:Ventures a venture capital firm or an accelerator?
Re:Ventures operates as a private accelerator, not a traditional venture capital firm. It deploys capital across seed, start-up, and early growth stages and is designated as a TIPS operator under the South Korean government's technology-startup program, which lets it channel public R&D grants alongside its own funds.
What is Re:Ventures' most notable portfolio company?
Rebellions, the AI semiconductor fabless startup, is the firm's standout position. Rebellions closed a KRW 165 billion Series B round in 2023, merged with Sapeon Korea in early 2025 to create a venture valued around KRW 1.3 trillion, and counts KT, Aramco's Wa'ed Ventures, and Temasek unit Pavilion Capital among its backers.
Which sectors does Re:Ventures primarily target?
The portfolio covers AI and semiconductor hardware, digital health and surgical robotics, health-focused consumer brands, agri-tech platforms, fashion recommerce, and digital healthcare marketplaces. The firm does not publish an explicit exclusion list, but its stamp follows founders deploying technology into large physical-world or consumption markets.
Does Re:Ventures invest only in South Korea?
While the firm itself is headquartered in Daejeon with no disclosed overseas offices, its portfolio companies actively expand abroad. Rebellions has struck commercial and investment partnerships in Saudi Arabia and Taiwan; Doctor Now has explored the Japanese market; Charaan operator MINE’S and Paiptree have signaled or commenced international activity.
What is the TIPS program, and how does it shape Re:Ventures' investment model?
TIPS is a South Korean government program that pairs private accelerators with public R&D funding to back early-stage deep-tech startups. Re:Ventures uses TIPS grants to de-risk pre-seed and seed rounds, often entering before institutional Series A investors, and then follows on with capital from its privately raised, KRW 100 billion-plus fund base.
Who manages the firm's investment decisions?
Re:Ventures does not publicly name its investment committee, managing partners, or executive team on its website, and no independent biography of a named investment head appears in the available materials. The firm identifies itself only at the entity level; its principals remain undisclosed.
Does Re:Ventures participate in syndicated rounds or follow-on investments?
Yes. In portfolio companies such as Connetive, Re:Ventures invested alongside DSC Investment, Stonebridge Ventures, and Schmidt via an individual investment association. The firm’s model includes both initial-discovery cheques and capacity for follow-on deployments as startups graduate toward Series A and B rounds with institutional co-investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: